TY  - JOUR 
T1  - Primary refractory B-cell lymphoblastic leukemia with extramedullary disease - a distinctive response to blinatumomab and inotuzumab ozogamicin
JO  - Hematology, Transfusion and Cell Therapy
A1  - Silva, Wellington Fernandes da
A1  - Marquez, Gabriel Lacerda
A1  - Salim, Rafael Calil
A1  - Rocha, Vanderson
SN  - 2531-1379
UL  - 10.1016/j.htct.2018.11.004
VL  - 41 
Y1  - 2019
PB  - Brasil 
ER  -